A SOY PROTEIN ISOLATE RICH IN GENISTEIN AND DAIDZEIN AND ITS EFFECTS ON PLASMA ISOFLAVONE CONCENTRATIONS, PLATELET-AGGREGATION, BLOOD-LIPIDS AND FATTY-ACID COMPOSITION OF PLASMA PHOSPHOLIPID IN NORMAL MEN
Mj. Gooderham et al., A SOY PROTEIN ISOLATE RICH IN GENISTEIN AND DAIDZEIN AND ITS EFFECTS ON PLASMA ISOFLAVONE CONCENTRATIONS, PLATELET-AGGREGATION, BLOOD-LIPIDS AND FATTY-ACID COMPOSITION OF PLASMA PHOSPHOLIPID IN NORMAL MEN, The Journal of nutrition, 126(8), 1996, pp. 2000-2006
The effects of consuming a soy protein isolate beverage powder (60 g/d
for 28 d) vs. a casein supplement was evaluated in 20 male subjects w
ho were randomly allocated into the two groups. A dramatic rise in pla
sma isoflavone concentrations was observed after supplementation in th
e soy protein group, the levels reaching 907 +/- 245 nmol/L for genist
ein (a 110-fold increase) and 498 +/- 102 nmol/L for daidzein (a 150-f
old increase) as measured by isotope dilution gas chromatography - mas
s spectrometry. These concentrations are higher than previously report
ed for the plasma of Japanese subjects consuming a traditional diet (2
76 nmol/L and 107 nmol/L, respectively). No significant differences in
collagen- or 9,11-dideoxy-11 alpha, 9 alpha-epoxymethanoprostaglandin
F-2 alpha (U46619)-induced platelet aggregation were observed in plat
elet-rich plasma from the two groups; the increase in plasma isoflavon
oids from soy protein supplementation is not sufficient to significant
ly inhibit platelet aggregation ex vivo. Similarly, plasma total and H
DL-cholesterol were not affected by protein supplementation, possibly
because the men were, normocholesterolemic at entry. Analysis of plasm
a phospholipid polyunsaturated fatty acid composition showed no differ
ences between soy protein and casein supplementation. Previous investi
gations reported a significant alteration in fatty acid status in anim
als fed soy protein relative to those fed casein. The present studies
indicate that although soy protein supplementation to a typical Wester
n diet can increase plasma concentrations of isoflavones, this may not
necessarily be sufficient to counter heart disease risk factors such
as high plasma cholesterol and platelet aggregation.